Author Kool, Marcel
-
2013 | Journal Article
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Zhukova, N.; Ramaswamy, V.; Remke, M.; Pfaff, E.; Shih, D. J. H.; Martin, D. C. & Castelo-Branco, P. et al. (2013)
Journal of Clinical Oncology, 31(23) pp. 2927-+. DOI: https://doi.org/10.1200/JCO.2012.48.5052
Details DOI PMID PMC WoS
-
2014 | Journal Article | Letter Note
Subgroup-specific localization of human medulloblastoma based on pre-operative MRI
Wefers, A. K.; Warmuth-Metz, M.; Poeschl, J.; von Bueren, A. O.; Monoranu, C.-M.; Seelos, K. & Peraud, A. et al. (2014)
Acta Neuropathologica, 127(6) pp. 931-933. DOI: https://doi.org/10.1007/s00401-014-1271-5
Details DOI PMID PMC WoS
-
2014 | Journal Article |
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Zhukova, N.; Ramaswamy, V.; Remke, M.; Martin, D. C.; Castelo-Branco, P.; Zhang, C. H. & Fraser, M. et al. (2014)
Acta Neuropathologica Communications, 2(1) art. 174. DOI: https://doi.org/10.1186/s40478-014-0174-y
Details DOI PMID PMC
-
2014 | Journal Article |
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Pietsch, T.; Schmidt, R.; Remke, M.; Korshunov, A.; Hovestadt, V.; Jones, D. T. W. & Felsberg, J. et al. (2014)
Acta Neuropathologica, 128(1) pp. 137-149. DOI: https://doi.org/10.1007/s00401-014-1276-0
Details DOI PMID PMC WoS
-
2016 | Conference Abstract
PROGNOSTIC RELEVANCE OF EPIGENETIC/BIOLOGICAL SUBGROUPS AND MYCC/MYCN GENE AMPLIFICATION IN A HOMOGENOUSLY TREATED METASTATIC MEDULLOBLASTOMA HIT2000 COHORT AGED 4-21 YEARS
von Bueren, A. O.; Jones, D. T. W.; Goschzik, T.; Kortmann, R.-D.; von Hoff, K.; Friedrich, C. & Mynarek, M. et al. (2016)
Neuro-Oncology, 18 17th International Symposium on Pediatric Neuro-Oncology (ISPNO), Liverpool, ENGLAND.
Cary: Oxford Univ Press Inc.
Details WoS
-
2016 | Journal Article
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Sturm, D.; Orr, B.; Toprak, U.; Hovestadt, V.; Jones, D.; Capper, D. & Sill, M. et al. (2016)
Cell, 164(5) pp. 1060-1072. DOI: https://doi.org/10.1016/j.cell.2016.01.015
Details DOI
-
2016 | Journal Article
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters
von Bueren, A. O.; Kortmann, R.-D.; von Hoff, K.; Friedrich, C.; Mynarek, M.; Mueller, K. & Goschzik, T. et al. (2016)
Journal of Clinical Oncology, 34(34) pp. 4151-+. DOI: https://doi.org/10.1200/JCO.2016.67.2428
Details DOI PMID PMC WoS
-
2018 | Journal Article
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma
Merk, D. J.; Ohli, J.; Merk, N. D.; Thatikonda, V.; Morrissy, S.; Schoof, M. & Schmid, S. N. et al. (2018)
Developmental Cell, 44(6) pp. 709-724.e6. DOI: https://doi.org/10.1016/j.devcel.2018.02.012
Details DOI
-
2018 | Journal Article |
The landscape of genomic alterations across childhood cancers
Gröbner, S. N.; Worst, B. C.; Weischenfeldt, J.; Buchhalter, I.; Kleinheinz, K.; Rudneva, V. A. & Johann, P. D. et al. (2018)
Nature, 555(7696) pp. 321-327. DOI: https://doi.org/10.1038/nature25480
Details DOI
-
2019 | Journal Article
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series
Benesch, M.; Mynarek, M.; Witt, H.; Warmuth‐Metz, M.; Pietsch, T.; Bison, B. & Pfister, S. M. et al. (2019)
The Oncologist, 24(9). DOI: https://doi.org/10.1634/theoncologist.2018-0489
Details DOI
-
2020 | Journal Article
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Mynarek, M.; von Hoff, K.; Pietsch, T.; Ottensmeier, H.; Warmuth-Metz, M.; Bison, B. & Pfister, S. et al. (2020)
Journal of Clinical Oncology, 38(18) pp. 2028-2040. DOI: https://doi.org/10.1200/JCO.19.03057
Details DOI
-
2020 | Journal Article |
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Suwala, A. K.; Stichel, D.; Schrimpf, D.; Kloor, M.; Wefers, A. K.; Reinhardt, A. & Maas, S. L. N. et al. (2020)
Acta Neuropathologica, 141(1) pp. 85-100. DOI: https://doi.org/10.1007/s00401-020-02243-6
Details DOI